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Abstract 
Aims: The objective of this study is to externally validate the SOAR stroke score (Stroke 
subtype, Oxfordshire Community Stroke Project Classification, Age, and pre-stroke modified 
Rankin score) in predicting hospital length of stay (LOS) following an admission for acute 
stroke. 
Methods: We conducted a multi-centre observational study in eight National Health Service 
hospital trusts in the Anglia Stroke & Heart Clinical Network between September 2008 and 
April 2011.  The usefulness of the SOAR stroke score in predicting hospital LOS in the acute 
settings was examined for all stroke and then stratified by discharge status (discharged alive 
or died during the admission). 
Results: A total of 3,597 patients (mean age 77 years) with first-ever or recurrent stroke 
(92% ischaemic) were included.   Increasing LOS was observed with increasing SOAR stroke 
score (p<0.001 for both mean and median) and the SOAR stroke score of 0 had the shortest 
mean LOS (12±20 days) while the SOAR stroke score of 6 had the longest mean LOS (26±28 
days).  Among participants who were discharged alive, increasing SOAR stroke score had a 
significantly higher mean and median LOS (p<0.001 for both mean and median) and the LOS 
peaked among participants with score value of 6 (mean (sd) 35±31 days, median (IQR) 23 
(14-48) days).  For participants who died as in-patient, there was no significant difference in 
mean or median LOS with increasing SOAR stroke score (p=0.68 &p=0.79 respectively).  
Conclusion: This external validation study confirms the usefulness of the SOAR stroke score 
in predicting LOS in patients with acute stroke especially in those who are likely to survive to 
discharge. This provides a simple prognostic score useful for clinicians, patients and service 
providers. 
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What's known? 
 Previous studies have identified predictors of length of stay (LOS) in acute stroke. 
 Currently, there has yet to be a system that is routinely implemented  to predict LOS 
in acute stroke.   
 We previously developed the SOAR stroke score to predict mortality and LOS among 
stroke patients but this score has not been externally validated for LOS outcome. 
What's new? 
 We have confirmed the usefulness of the SOAR stroke score in predicting 
LOS.Higher scores were associated with prolonged hospital stay among patients who 
survived to discharge.  
 The SOAR stroke score can be routinely implemented to provide likely LOS of acute 
stroke admissions for service providers, healthcare staff and patients and relatives 
particularly in lower range where the chance of survival to discharge is greater. 
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Introduction 
Stroke is a major cause of mortality and morbidity in Westernized societies1 and the delivery 
of stroke care poses a major economic burden.2  Among the factors that contribute to the total 
costs of hospitalization, length of stay (LOS) is highly predictive of inpatient costs.3  One 
study suggested that LOS accounted for 43% of the variance in total cost in ischaemic 
stroke.4  Accurate predictions of LOS provides useful prognostic information for clinicians 
which may affect clinical decision making and patients and families may benefit from a better 
understanding of what to expect.  Furthermore, it provides useful information to service 
providers in managing their services to meet the potential demands.  Consequently, accurate 
prediction of LOS has become increasingly important for the patients, hospital administrators 
and healthcare systems including commissioning and purchasing organizations. 
 
Previous studies have identified some predictors of LOS in acute stroke.  The NIHSS score 
has been evaluated for prediction of LOS after first-ever ischemic stroke.3  The PLOS score 
(which includes stroke severity, stroke type, decrease level of consciousness on admission, 
history of congestive heart disease and prior atrial fibrillation) has been shown to be 
predictive of LOS in both derivation and validation cohorts (c statistic 0.69 and 0.68, 
respectively).5 Other studies have identified other independent predictors of LOS after stroke 
such as prestroke dementia, smoking, diabetes and atrial fibrillation.6,7  While it may be 
interesting to identify factors that are associated with increased LOS,  for clinicians a scoring 
system which is highly predictive of LOS and that could be implemented easily in daily 
clinical practice would be ideal.  Currently, there has yet to be a system that is both validated 
and routinely implemented to predict LOS in acute stroke.   
 
We previously developed and internally validated the SOAR stroke score which predicts 
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mortality and LOS among stroke patients in a large dataset involving 12,355 patients with 
acute stroke.8  This simple prognostic score based on Stroke subtype, Oxfordshire Stroke 
Community Project classification, Age and pre-stroke modified Rankin has the advantage of 
including variables which are relative fixed (unlike NIHSS which may change rapidly), easy 
to remember and easily collectable by the clinical team. This score has been subsequently 
validated for its usefulness in predicting in-hospital and early (within 7-day) mortality using 
an independent dataset.9  Whilst the score was developed with the view of predicting 
mortality based on predictors of mortality outcome, we also found that it predicted in-hospital 
LOS.8 If this was verified in an independent sample, the SOAR stroke score will have added 
value over other scores which either predicts mortality or LOS alone. Therefore, in this study, 
we aimed to validate the SOAR stroke score for LOS prediction using an independent patient 
cohort. 
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Methods 
 
Participants 
The study sample was drawn from the Anglia Stroke & Heart Clinical Network (AS&HCN) 
database which routinely collected data on consecutive stroke admissions between September 
2008 and April 2011 in eight NHS hospital trusts in the East of England across three 
counties, Norfolk, Suffolk and Cambridgeshire with the catchment population of ~2.5 
million.  The East of England Strategic Health Authority (SHA) set up the AS&HCN to 
support the development of stroke services within the region and to monitor the progress in 
the East of England. Data collection for AS&HCN began at the point of admission to the 
acute hospital and terminated at the point of patient’s discharge from the acute hospital. 
Anglia Stroke Clinical Network Evaluation Study (ASCNES) was set up with the data 
sharing agreement with AS&HCN and the study methodology & robustness of study methods 
have been previously reported. [PKM1] 
 
 
Selection criteria 
Patients included were confirmed stroke cases (either ischaemic or haemorrhagic stroke) 
based on clinical history and neuroradiological investigations (CT and/or MRI) and therefore 
transient ischemic attacks and other vascular causes of neurological deficits presenting with 
stroke-like symptoms (e.g. subdural hematoma and subarachnoid haemorrhages) were 
excluded. We also excluded patients who were admitted to Norfolk and Norwich University 
Hospital prior to February 2010 because they were included in the original SOAR stroke 
score derivation cohort study.8 
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Data collection 
Stroke cases were identified prospectively by the clinical teams caring for the patients.  
Anonymised data from each hospital were sent on a monthly basis to the AS&HCN which 
collates the data on clinical service activities of the eight hospitals within the network in 
order to monitor and evaluate the services in relation to National targets and acute stroke 
management guidelines of the Royal College of Physicians and National Institute of Health & 
Clinical Excellence.10 
 
The follow up time started at baseline for this study (date of study enrolment) and ended at 
end of March 2009 for CVD events and end of December 2011 for mortality outcome.  
 
SOAR stroke score 
We previously derived the SOAR stroke score with score values ranging from 0 to a 
maximum of 7  that included Stroke subtype (ischaemic or haemorrhagic), OCSP 
(Oxfordshire Community Stroke Project) classification, Age and prestroke modified Rankin 
which are measured at the time of admission.  For stroke subtype, 1 point is assigned for 
haemorrhagic stroke.  For the OCSP classification, 1 point is assigned for posterior 
circulation stroke and 2 points for total anterior circulation stroke.  For age, 1 point is 
assigned for age 66-85 years and 2 points for age greater than 85 years.  For prestroke 
modified Rankin, 1 point is assigned for a score of 3 or 4 and 2 points  for a score of 5.  The 
overall SOAR stroke prognostic score was the sum of the points designated for these four 
variables. 
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Statistical analysis 
Statistical anaysis was performed using STATA 13.0 (College Station, USA).  The score 
value for an individual was calculated as per the SOAR scoring system (Appendix 1). The 
frequency distritbution of baseline characteristics of subjects in the cohort, mean and standard 
deviation of LOS and median and interquartile range of LOS were also calculated for each 
value of SOAR stroke score.  The cohort was then stratified by discharge status (discharged 
alive or died during the admission) and LOS was evaluated for each score.  Comparisons of 
LOS and SOAR stroke score values were performed using a one-way analysis of variance for 
comparison of means and the nonparametric K-sample test on equality of medians for 
comparison of medians. In addition, we compared the LOS for the derivation and validation 
studies graphically and in table format. 
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Results 
 
A total of 3,597 patients with first-ever or recurrent stroke who were admitted between 
September 2008 and April 2011 (from Feb 2010 in Norwich to avoid overlap with the 
derivation study of SOAR score)8 were included in the current study. Their characteristics 
with regard to the SOAR variables are shown in Table 1.  The mean age of the patients was 
77 years (SD 12 years) and 92% of them had an ischaemic stroke, with 38% having an OCSP 
diagnosis of a partial anterior circulation stroke .  Half of the patients in this study did not 
have any disability prior to stroke and a total of 15% of them died during the admission.  The 
SOAR score and crude death rate has been previously reported in this cohort by our group.9  
The characteristics of the patients with missing values who were not included in the analysis 
are shown in Appendix 2. 
 
SOAR score and mortality 
The mortality rate and 95% confidence interval is shown in Appendix 3.  The mortality rate 
ranged from 1.2% to 61% with higher mortality with increasing score from SOAR score of 0 
to 6.   We observed no patients who had a SOAR score of 7 in this validation cohort. The 
detailed results of the validation study of SOAR stroke in predicting mortality have been 
previously reported.9  
 
SOAR score and length of stay 
For the derivation and validation (current) study, the mean and median LOS for the full 
cohort and then stratified by discharge status are presented in Table 2.  For the validation 
study there was an increasing LOS with increasing score for the full cohort (p<0.001 for both 
mean and median) and the SOAR stroke score of 0 had the shortest mean LOS (12±20 days) 
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while the SOAR stroke score of 6 had the longest mean LOS (26±28 days).  Among 
participants who were discharged alive, increasing SOAR stroke score had a significantly 
higher mean and median LOS (p<0.001 for both mean and median) and the LOS peaked 
among participants with score value of 6 (mean (sd) 35±31 days, median (IQR) 23 (14-48) 
days).  For participants who died as in-patient, there was no significant difference in LOS 
with increasing SOAR stroke score (p=0.68 for mean, p=0.79 for median) and the mean LOS 
ranged from 8 to 22 days.  Similar results were present for the derivation cohort.  A 
comparison of the LOS of the derivation and validation cohort was shown graphically in 
Figures 2 and 3 for comparison of mean and median, respectively.  
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Discussion 
 
This validation study confirms that the SOAR stroke score is also useful in predicting LOS in 
patients with acute stroke in addition to mortality prediction.  The SOAR stroke score 
performed as expected as higher scores were associated with prolonged hospital stay among 
patients who are discharged alive but the performance was inconsistent for patients[PKM2] who 
died as an inpatient. The inconsistency for predicting LOS in patients who died may be due to 
the fact that the score was derived to predict in-hospital death and thus may not perform as 
well for LOS in those who died.  Nonetheless, the performance of the SOAR stroke score 
score is very good for those who are discharged alive albeit with some inconsistency at the 
very high scores perhaps due to small sample size in this category.   
 
Predicting length of stay in stroke is complex.  Stroke patients are heterogeneous in terms of 
baseline function and severity of stroke.  Furthermore, whilst the majority of stroke occurs in 
older age, there is wide age range as it also affects younger people. Some patients present 
with mild stroke while others present with very severe disabiling stroke and this has a strong 
influence on length of stay as well as inpatient mortality or survival to discharge. This could 
be further complicated by the fact that some very severe stroke (e.g. who scored 6) may be 
discharged alive for palliation in the community with expected death occuring shortly after 
the discharge. Nevertheless, this may not concern the health system management in term of 
secondary care resource use. It should be noted that the SOAR stroke score was designed 
based on predictors of mortality.  Of note the length of stay in stroke may be influenced by 
the aggressiveness of management and the individual patient’s susceptibility to 
complications.  For patients with good baseline function and mild stroke who eventually are 
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discharged the score has very good predictive value as there is a higher certainty that the 
patient will be discharged alive.  
 
While many demographic, clinical and functional factors have been reported to influence 
LOS in acute stroke, there are inconsistencies among the studies.  In a population based study 
of 346 stroke patients, initial stroke severity was the only significant predictor of length of 
stay in hospital.11  A Swedish study found that independent predictors of acute LOS were 
stroke severity, lacunar stroke, dementia and smoking. In addition, a Chinese study of over 
5000 patients found that stroke type has been reported to influence LOS.12  An Australian 
study of over 6000 patients with first-ever stroke found that hospital stays were longer for 
females and those who were admitted to specialist stroke units.13  In-hospital complications 
have also to be shown to be associated with longer LOS in acute stroke.14  Higher quality of 
care during the early phase of stroke has also been reported as associated with reduced LOS 
among patients with stroke.15  Some of the differences in findings may reflect different 
measures evaluated in each study. No study to date has attempted to develop an easy score 
that correlated very well with the LOS outcome.  
 
The predictive accuracy of the SOAR stroke score may relate to the fact that the individual 
variables included in this scoring system are  important prognostic indicators of stroke. 
Stroke type has been shown to be predictive of LOS.12  Age has been shown to have 
prognostic impact as very old age has been shown to be a strong predictor of outcome and 
mortality after stroke.16 In the SOAR score, stroke severity is captured by OSCP 
classification.  More severe stroke according to the OSCP classification17,18 and high pre-
morbid Rankin scores19,20 in stroke are associated with poor outcomes which may influence 
patient LOS.   
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The SOAR stroke score has several strengths. In contrast to other suggested stroke prognostic 
scores to date, our score contains only four variables, which are easy to obtain thus makes it 
much simpler and user friendly.  In addition, it can be easily implemented by any clinician at 
the point of stroke diagnosis.  The score is universally applicable as the parameters included 
in the score are readily available which increases the likelihood of the score being adopted by 
clinicians in their routine clinical practice.  In addition, the score can be calculated by non-
clinical staff for administrative purposes once a clinical assessment has been made.  An 
important advantage of the SOAR score is that the variables included are mainly fixed at time 
of assessment unlike variables such as glucose, blood pressure of NIHSS score which are 
subject to variation over time.  Another strength of the study is that it is derived from 8 
hospitals in the UK from 3 counties which would capture variations in stroke services, thus 
results are more likely to be generalizable.  Unlike other scores which are specific to 
ischaemic stroke21 and stroke patients who received intravenous thrombolysis,22 this score 
can be applied to predict LOS outcome for both stroke subtypes.    
 
Our study has some limitations. Variables such as age, stroke subtype, OSCP classification 
and premorbid Rankin were statistically significantly different between the included and 
excluded patients.  The excluded group has a much higher rate of hemorrhagic stroke and this 
may suggest that there was a greater extent of missing data for patients with more severe 
stroke subtypes, e.g. unable to ascertain pre-stroke modified Rankin.   For age and the pre-
stroke modified Rankin score, the patients excluded had slightly higher proportion of patients 
who were in the youngest and oldest groups and in the least disabled and most disabled 
groups.  The truncation of distribution however would only attenuate the associations. 
Furthermore, the internal relationship between the score and outcomes examined would not 
have been affected by the missing data. Furthermore, the data showed expected results, i.e. 
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the higher the score, the higher the mortality outcomes, and thus has internal validity. 
Furthermore we have shown that the  score performance score is reproducible in both 
derivation (internal validation) and the currently reported external validation cohorts. The 
score was validated using hospital based data and thus did not capture patients with mild 
strokes and patients who died in the community due to severe stroke who were not admitted 
to the hospital. Nonetheless, the majority of patients with stroke are admitted to hospital 
making the score relevant to stroke prognosis.    
 
One of the potential limitations is the possibility of inter-rater variability in the measurement 
of prestroke modified Rankin score which was collected from medical documents, nursing 
records or from a proxy, usually relatives or carers. However, the way the SOAR score is 
categorized for aggregated scores for the prestroke modified Rankin (0-2, 3-4 and 5)  
minimizes the impact of inter-rater variability on the score value.  Finally, the OCSP 
classification can be difficult to measure acurately because the patients’ condition may 
change in some cases e.g. from total anterior circulation to partial anterior circulation stroke 
depending on the exact timing of stroke onset and assessment. Nonetheless,  major 
neurological fluctuations are less likely to happen compared to other biochemical parameters 
or physiological variables such as blood pressure or glucose levels. 
 
Future studies should test the usefulness of SOAR score in predicting hospital length of stay 
in different healthcare settings (community and hospital based) as well as in different ethnic 
groups to examine the generalisability of its clinical utility.  The outcome of stroke is 
invariably linked to the quality and efficiency of services hence the SOAR score can serve as 
a benchmarking tool to determine the efficiency and outcome of services. This will provide a 
valuable assessment tool for service users and care service commissioners to use to determine 
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services to buy, and for service providers to ensure the expected standards are met. Further 
studies should also be undertaken to evaluate how clinical judgement compares to the SOAR 
score in predicting length of hospital stay.   
 
Conclusions 
In summary, this validation study found that the SOAR score acurrately predicts LOS in 
acute stroke.  This four variable score is simple and can be implemented at time of diagnosis 
to provide service users, healthcare staff and commisioners about likely LOS of acute stroke 
admissions.  The score also has the potential to be utilized as a benchmarking tool to evaluate 
if service providers meet the expected standards. 
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Figure 1: Mean length of stay (corresponding 95% CI) of patients scoring 0-6 by SOAR 
Stroke Score in derivation and validation (current) study according to discharge status 
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Figure 2: Median length of stay (IQR) of patients scoring 0-6 by SOAR Stroke Score in 
derivation and validation (current) study according to discharge status 
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Table 1: Demographic data of patients 
Variable N %/SD 
Age (mean / SD) 3597 77 (±12) 
Female 1822 51% 
Male 1775 49% 
Ischaemic  3308 92% 
Haemorrhage 289 8% 
mRs   
0 1809 50% 
1 607 17% 
2 460 13% 
3 412 11% 
4 236 7% 
5 72 2% 
6 1 0.03% 
Bamford classification   
LACS 929 26% 
PACS 1361 38% 
POCS 542 15% 
TACS 765 21% 
Discharge status   
Alive 3001 85% 
Dead 536 15% 
SD = standard deviation, mRs = modified Rankin score, LACS = lacunar stroke, PACS = 
partial anterior circulation stroke, POCS = posterior circulation stroke, TACS = total anterior 
circulation stroke. 
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Table 2: Length of stay by SOAR Stroke Score in derivation and validation study 
SOAR Score Derivation study Validation study (current study) 
N Mean (SD) Median (IQR) N Mean (SD) Median (IQR) 
0 766 10 (±19) 6 (3-12) 340 12 (±20) 6 (2-12) 
1 2313 11 (±17) 7 (4-13) 1221 16 (±22) 8 (3-19) 
2 4130 14 (±16) 10 (5-17) 905 18 (±24) 9 (4-24) 
3 2588 15 (±17) 10 (6-19) 621 19 (±26) 10 (4-24) 
4 1766 17 (±19) 12 (5-24) 334 20 (±29) 12 (5-25) 
5 668 16 (±19) 11 (5-22) 142 21 (±26) 12 (4-28) 
6 or 7 124 13 (±13) 9 (4-19.5) 34 26 (±28) 16 (5-32) 
       
Alive at discharge       
0 754 10 (±19) 6 (3-11) 333 12 (±20) 6 (2-12) 
1 2220 11 (±16) 7 (4-13) 1149 16 (±22) 8 (3-19) 
2 3690 14 (±16) 9 (6-17) 813 18 (±24) 9 (4-23) 
3 2034 16 (±17) 11 (6-20) 468 20 (±28) 10 (4-25) 
4 943 22 (±20) 17 (9-29) 170 18 (±19) 11 (5-24) 
5 249 24 (±24) 18 (11-29) 55 21 (±23) 13 (4-31) 
6 or 7 30 23 (±18) 19.5 (9-33) 13 35 (±31) 23 (14-48) 
Dead at discharge       
0 12 12 (±12) 10 (2.5-17) 4 8 (±10) 4.5 (0.5-15) 
1 93 15 (±30) 10 (5-16.5) 55 18 (±17) 10 (5-28) 
2 440 16 (±17) 11 (4-21) 81 19 (±22) 12 (4-26) 
3 554 13 (±18) 8 (3-18) 139 17 (±22) 10 (3-23) 
4 823 12 (±16) 7 (3-16) 153 20 (±20) 13 (5-28) 
5 419 12 (±14) 7 (3-15) 85 22 (±28) 11 (4-27) 
6 or 7 94 10 (±10) 7 (3-17) 19 18 (±20) 12 (3-23) 
SD=standard deviation, IQR=interquartile range
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Appendix 1: The SOAR Stroke Score described in tabular form 
 SOAR Stroke Prognosis Score   
Point Age Stroke subtype OCSP Pre-stroke disability 
0 ≤65  Infarct LACS/PACS mRs 0-2 
1 66-85 Haemorrhage POCS mRs  3-4 
2 >85 - TACS mRs 5 
Score for each 
factor 
    
Total      
mRs = modified Rankin score  
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Appendix 2: Demographic data of patients excluded due to missing data 
Variable Mean/N SD/% 
Age (mean / SD) 5325 76 (±13) 
Female 2685 52% 
Male 2521 48% 
Ischaemic 3769 83% 
Haemorrhage 766 17% 
MRs   
0 949 54% 
1 306 17% 
2 155 9% 
3 190 11% 
4 135 8% 
5 34 2% 
6 1 0.06% 
Bamford classification   
LACS 375 23% 
PACS 697 43% 
POCS 209 13% 
TACS 351 22% 
Discharge status   
Alive 3649 79% 
Dead 995 21% 
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Appendix 3: SOAR Stroke Score and risk of mortality ([PKM4]corresponding 95% CI) in 
current study 
 
The in-hospital mortality rate (95%CI) for each point of SOAR Stroke Score in the current 
cohort  
 
27 
 
References 
1. Stroke Association. Stroke Statistics 2013.  Available at 
http://www.stroke.org.uk/resource-sheet/stroke-statistics. Accessed December 24, 
2013. 
 
2. Di Carlo A. Human and economic burden of stroke. Age Ageing 2009;38:4-5. 
 
3. Chang KC, Tseng MC, Weng HH, et al. Prediction of length of stay of first-ever 
ischemic stroke. Stroke 2002;33:2670-2674. 
 
4. Diringer MN, Edwards DF, Mattson DT, et al. Predictors of acute hospital costs for 
treatment of ischemic stroke in an academic center. Stroke 1999;30:724-8. 
 
5. Koton S, Bornstein NM, Tsabari R, et al; NASIS Investigators. Derivation and 
validation of the prolonged length of stay score in acute stroke patients. Neurology 
2010;74:1511-6. 
 
6. Appelros P: Prediction of length of stay for stroke patients. Acta Neurol Scand 
2007;116:15–19. 
 
7. Huang YC, Hu CJ, Lee TH, et al. The impact factors on costs and length of stay 
among acute ischemic stroke. J Stroke Cerebrovasc Dis 2013;22:e152-8. 
 
8. Myint PK, Clark AB, Kwok CS, et al. A simple 8-point score strongly predicts early 
outcomes in acute stroke. Int J Stroke 2014;9:278-83. 
28 
 
 
9. Kwok CS, Potter JF, Dalton G, et al; On behalf of the Anglia Stroke Clinical Network 
Evaluation Study (ASCNES) Group. The SOAR Stroke Score Predicts Inpatient and 
7-Day Mortality in Acute Stroke. Stroke 2013;44:2010-2012. 
 
10. National clinical guidelines for stroke. 4th edition.  Incorporating the 
recommendations from Stroke: national clinical guidelines for diagnosis and initial 
management of acute stroke and transient ischaemic attack (TIA) by the National 
Institute for Health and Clinical Excellence.  Available at 
http://www.rcplondon.ac.uk/publications/stroke-national-clinical-guideline-diagnosis-
and-initial-management-acute-stroke-and-tr. Accessed December 24, 2013. 
 
11. Luengo-Fernandez R, Gray AM, Rothwell PM. Population based study of 
determinants of initial secondary care costs of acute stroke in the United Kingdom. 
Stroke 2006;37:2579–2587. 
 
12. Li Y, Liu H, Wang J, Li Y et al. Variable lengths of stay among ischemic stroke types 
in Chinese general teaching hospitals. PLoS One 2012;7:e45101. 
 
13. Somerford PJ, Lee AH, Yau KK. Ischemic stroke hospital stay and discharge 
destination. Ann Epidemiol 2004;14:773-7. 
 
14. Ingeman A, Andersen G, Hundborg HH, et al. In-hospital medical complications, 
length of stay, and mortality among stroke unit patients. Stroke 2011;42:3214-8. 
 
29 
 
15. Svendsen ML, Ehlers LH, Andersen G, et al. Quality of care and length of hospital 
stay among patients with stroke. Med Care 2009;47:575–582. 
 
16. Kammersgaard LP, Jorgensen HS, Reith J, et al; Copenhagen Stroke Study. Short- 
and long-term prognosis for very old stroke patients. The Copenhagen Stroke Study. 
Age Ageing 2004; 33:149–154. 
 
17. Tei H, Uchiyama S, Ohara K, et al. Deteriorating ischemic stroke in 4 clinical 
categories classified by the Oxfordshire Community Stroke Project. Stroke 
2000;31:2049-54. 
 
18. Paci M, Nannetti L, D'Ippolito P, et al. Outcomes from ischemic stroke types 
classified by the Oxfordshire Community Stroke Project: a systematic review. Eur J 
Phys Rehabil Med 2011;47:19-23. 
 
19. Kwok CS, Clark A, Ford GA, et al. Association between pre-stroke disability and in-
patient mortality and length of acute hospital stay following acute stroke. J Am 
Geriatr Soc 2012;60:726-32. 
 
20. Huybrechts KF. Caro JJ, Xenakis J, et al. The prognostic value of the modified 
Rankin scale score for long-term survival after first-ever stroke. Cerebrovasc Dis 
2008;26:381-387. 
 
30 
 
21. Lee J, Morishima T, Kunisawa S, et al. Derivation and validation of in-hospital 
mortality prediction models in ischaemic stroke patients using administrative data. 
Cerebrovasc Dis 2013;35:73-80. 
 
22. Giralt-Steinhauer E, Rodriguez-Campello A, Cuadrado-Godia E, et al. External 
validation of the DRAGON score in elderly Spanish population: prediction of stroke 
prognosis after IV thrombolysis. Cerebrovasc Dis 2013;36:110-4. 
